New Current Report Filed with the SEC Disclosing Receipt of a Notice of Delisting, the Failure to Satisfy a Continued Listing Rule or Standard or the Transfer of a Listing: 8-K – DERMA SCIENCES, INC. (0000892160) (Filer)

A current report on Form 8-K was just filed with the U.S. Securities & Exchange Commission (SEC) disclosing receipt of a notice of delisting, the failure to satisfy a continued listing rule or standard or the transfer of a listing. Details of the current report are:

8-K – DERMA SCIENCES, INC. (0000892160) (Filer)
Filed: 2017-02-24 AccNo: 0001193125-17-055055 Size: 99 KB

Item 2.01: Completion of Acquisition or Disposition of Assets

Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Item 3.03: Material Modifications to Rights of Security Holders

Item 5.01: Changes in Control of Registrant

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Item 9.01: Financial Statements and Exhibits
Filing Date: 2017-02-24T08:29:56-05:00

This is a breaking news story. You can access the complete current report through the SEC’s Edgar system: http://www.sec.gov/Archives/edgar/data/892160/000119312517055055/0001193125-17-055055-index.htm